1. Effectiveness of ENDS, NRT and medication for smoking cessation among cigarette-only users: a longitudinal analysis of PATH Study wave 3 (2015–2016) and 4 (2016–2017), adult data
- Author
-
Alison Breland, Joanna E. Cohen, Bekir Kaplan, Panagis Galiatsatos, and Thomas Eissenberg
- Subjects
medicine.medical_specialty ,Health (social science) ,medicine.medical_treatment ,Population ,Logistic regression ,behavioral disciplines and activities ,chemistry.chemical_compound ,Acquired immunodeficiency syndrome (AIDS) ,health services administration ,mental disorders ,Medicine ,education ,Psychiatry ,Varenicline ,health care economics and organizations ,Bupropion ,education.field_of_study ,Cigarette Smoker ,business.industry ,Public Health, Environmental and Occupational Health ,Nicotine replacement therapy ,medicine.disease ,chemistry ,behavior and behavior mechanisms ,Smoking cessation ,business ,medicine.drug - Abstract
BackgroundResearch is inconclusive on the effectiveness of electronic nicotine delivery systems (ENDS) as cigarette cessation aids compared with nicotine replacement therapy (NRT) or non-NRT medication. This study compared the cigarette cessation rates for ENDS, NRT and non-NRT medication.MethodPopulation Assessment of Tobacco and Health Study wave 3 cigarette-only users who used ENDS, NRT or non-NRT medication (varenicline and bupropion) to quit smoking between wave 3 and 4 were included. ‘Cessation’ was defined as being a former cigarette smoker in wave 4. χ2, logistic regression, and a sensitivity analysis with Bayes factor assessed the association between quitting smoking and method used.ResultsAmong 6794 cigarette-only users, 532 used ENDS (n=75), NRT (n=289), non-NRT medication (n=68), or a combination of NRT and non-NRT medication (n=100) to quit smoking between wave 3 and 4. The percentages of quitting smoking among those who used ENDS, NRT, non-NRT medication, and a combination of NRT and non-NRT medication were 16.2% (n=14), 16.1% (n=47), 17.7% (n=13), and 14.8% (n=12), respectively (p=0.97). None of the cigarette-only users who used ENDS to quit smoking became ENDS-only users in wave 4; 37.6% became dual users of ENDS and cigarettes.ConclusionNo differences were found when cessation rates of ENDS, NRT or non-NRT medication were compared. Given uncertainty about the long-term health effect of ENDS and the likelihood of becoming dual users, people who smoke and need assistance quitting should be encouraged to use current Food and Drug Administration-approved cessation methods until more effective methods are developed.
- Published
- 2021
- Full Text
- View/download PDF